Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial
Titel:
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial
Auteur:
Richmond, Peter C Marshall, Helen S Nissen, Michael D Jiang, Qin Jansen, Kathrin U Garcés-Sánchez, Maria Martinón-Torres, Federico Beeslaar, Johannes Szenborn, Leszek Wysocki, Jacek Eiden, Joseph Harris, Shannon L Jones, Thomas R Perez, John L